🇺🇸 FDA
Patent

US 8349810

Methods for targeted cleavage and recombination of CCR5

granted A61PA61P31/12

Quick answer

US patent 8349810 (Methods for targeted cleavage and recombination of CCR5) held by Sangamo Biosciences, Inc. expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P31/12